Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 419-500-9 | CAS number: 171599-85-2 RED REN 363
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1996
- Reliability:
- 2 (reliable with restrictions)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid 5-hydroxy-napht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)-ethane-1,2-diamine, sodium salt
- EC Number:
- 419-500-9
- EC Name:
- N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid 5-hydroxy-napht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)-ethane-1,2-diamine, sodium salt
- Cas Number:
- 171599-85-2
- Molecular formula:
- C46H38Cl2N14O19S6
- IUPAC Name:
- tetrasodium 5-[(4-chloro-6-{[2-({4-chloro-6-[(7-{2-[4-(ethenesulfonyl)phenyl]diazen-1-yl}-8-hydroxy-3,6-disulfonatonaphthalen-1-yl)amino]-1,3,5-triazin-2-yl}(2-hydroxyethyl)amino)ethyl]amino}-1,3,5-triazin-2-yl)amino]-3-{2-[4-(ethenesulfonyl)phenyl]diazen-1-yl}-4-hydroxynaphthalene-2,7-disulfonate
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
Administration / exposure
- Vehicle:
- water
- Remarks:
- bidistilled water
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Male: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 0
Female: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 0 - Clinical signs:
- other: Signs of toxicity related to dose levels: - MORTALITY: No mortality occured during the study. - CLINICAL SIGNS: Diarrhea was observed in two males and three females between day 2 and 5 after treatment. - BODY WEIGHTS: No treatment related changes noted.
- Gross pathology:
- Effects on organs:
- MACROSCOPIC FINDINGS:
No organ abnormalities were observed at necropsy.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
